Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 20% ± 6% | |
macrophage | 7 studies | 23% ± 5% | |
epithelial cell | 5 studies | 26% ± 7% | |
endothelial cell of lymphatic vessel | 4 studies | 24% ± 10% | |
non-classical monocyte | 4 studies | 26% ± 7% | |
microglial cell | 4 studies | 26% ± 6% | |
classical monocyte | 3 studies | 24% ± 2% | |
GABAergic neuron | 3 studies | 45% ± 9% | |
glutamatergic neuron | 3 studies | 50% ± 13% | |
dendritic cell | 3 studies | 28% ± 6% | |
plasmacytoid dendritic cell | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 32% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4690.86 | 1445 / 1445 | 100% | 21.27 | 183 / 183 |
kidney | 100% | 5509.55 | 89 / 89 | 100% | 37.52 | 901 / 901 |
lung | 100% | 6602.63 | 578 / 578 | 100% | 25.79 | 1155 / 1155 |
pancreas | 100% | 3284.45 | 328 / 328 | 100% | 29.64 | 178 / 178 |
prostate | 100% | 6226.08 | 245 / 245 | 100% | 45.81 | 502 / 502 |
stomach | 100% | 4395.10 | 359 / 359 | 100% | 28.27 | 286 / 286 |
breast | 100% | 6125.83 | 459 / 459 | 100% | 35.01 | 1117 / 1118 |
thymus | 100% | 6422.76 | 653 / 653 | 100% | 41.32 | 604 / 605 |
intestine | 100% | 5834.83 | 966 / 966 | 100% | 32.03 | 526 / 527 |
bladder | 100% | 5670.33 | 21 / 21 | 100% | 26.98 | 503 / 504 |
skin | 100% | 3991.31 | 1809 / 1809 | 100% | 39.88 | 471 / 472 |
brain | 100% | 4274.36 | 2635 / 2642 | 100% | 46.11 | 705 / 705 |
ovary | 100% | 5485.62 | 180 / 180 | 100% | 26.20 | 428 / 430 |
liver | 100% | 3517.56 | 226 / 226 | 100% | 29.28 | 404 / 406 |
uterus | 100% | 6754.22 | 170 / 170 | 99% | 26.17 | 456 / 459 |
adrenal gland | 100% | 6890.62 | 258 / 258 | 99% | 32.95 | 228 / 230 |
adipose | 100% | 5697.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 49.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.19 | 29 / 29 |
muscle | 100% | 4631.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9274.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.54 | 45 / 45 |
blood vessel | 100% | 4882.10 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 5873.43 | 860 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2866.12 | 889 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140468 | Biological process | HRI-mediated signaling |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_1901526 | Biological process | positive regulation of mitophagy |
GO_1990641 | Biological process | response to iron ion starvation |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DELE1 |
Protein name | DAP3 binding cell death enhancer 1 DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)] |
Synonyms | DELE KIAA0141 |
Description | FUNCTION: Protein kinase activator that acts as a key activator of the integrated stress response (ISR) following various stresses, such as iron deficiency and mitochondrial stress . Detects impaired protein import and processing in mitochondria, activating the ISR . May also required for the induction of death receptor-mediated apoptosis through the regulation of caspase activation . .; FUNCTION: [DAP3-binding cell death enhancer 1]: Protein kinase activator that activates the ISR in response to iron deficiency: iron deficiency impairs mitochondrial import, promoting DELE1 localization at the mitochondrial surface, where it binds and activates EIF2AK1/HRI to trigger the ISR. .; FUNCTION: [DAP3-binding cell death enhancer 1 short form]: Protein kinase activator generated by protein cleavage in response to mitochondrial stress, which accumulates in the cytosol and specifically binds to and activates the protein kinase activity of EIF2AK1/HRI . It thereby activates the integrated stress response (ISR): EIF2AK1/HRI activation promotes eIF-2-alpha (EIF2S1) phosphorylation, leading to a decrease in global protein synthesis and the induction of selected genes, including the transcription factor ATF4, the master transcriptional regulator of the ISR . . |
Accessions | ENST00000194118.8 H0YA48 Q14154 ENST00000507481.2 ENST00000432126.7 D6RBI8 ENST00000508751.1 |